Dr. Calvin Kuo's group's research explores a variety of topics, including angiogenesis, intestinal stem/progenitor cell biology, and nanoparticle-mediated systemic siRNA delivery. The lab's focuses are in angiogenesis, oncogene discovery, endothelial cell regulation of physiology, and intestinal stem/progenitor biology.
January 19, 2021 - Stanford Medicine Scope
Stanford Bio-X affiliated faculty members Mark Davis, Calvin Kuo, Scott Boyd, Bill Robinson and Peter...
May 3, 2018 - Stanford Medicine News Center
When Stanford Bio-X founding faculty member James Spudich was diagnosed with lung cancer, researchers...
January 16, 2017 - Stanford Medicine News Center
A chronic inflammatory process that occurs in some, but not all, older people may trigger...
